Stock Market & Financial Investment News

News Breaks November 2, 2012 06:21 EDT WPI Watson Pharmaceuticals upgraded to Overweight from Neutral at Piper Jaffray Piper Jaffray upgraded Watson Pharmaceuticals citing an attractive risk/reward profile following the company's Q3 results. The firm raised its price target for shares to $103 from $77. News For WPI From The Last 14 Days Check below for free stories on WPI the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for WPI Sign up for a free trial to see the rest of the stories you've been missing.